Navigation Links
Orchid Cellmark Reports First Quarter 2008 Financial Results
Date:5/8/2008

penses 17,397 15,663

Operating loss (2,870) (1,631)

Other income, net 350 207

Loss before income tax expense (2,520) (1,424)

Income tax expense (benefit) (246) 259

Net loss $(2,274) $(1,683)

Basic and diluted net loss per share $(0.08) $(0.06)

Shares used in computing basic and

diluted net loss per share: 29,934 29,319

Orchid Cellmark Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

March 31, 2008 and December 31, 2007

(In thousands)

(Unaudited)

March 31, December 31,

2008 2007

Assets:

Current assets

Cash and cash equivalents $19,056 $20,918

Accounts receivable, net 9,993 9,516

Inventory 1,471 1,443

Prepaids and other current assets 1,588 2,151

Total current assets 32,108 34,028

Fixed assets, net 6,801 7,440

Goodwill 9,664 9,519

Other intangibles, net 9,214 9,694

Restricted cash 958 958

Other assets 504 490

Total assets $59,249 $62,129

L
'/>"/>

SOURCE Orchid Cellmark Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Orchid Cellmark to Open a New Forensic Facility in the United Kingdom to Meet Increasing Demand for Its Services
2. Orchid Cellmark Reports Fourth Quarter and Full Year 2007 Financial Results
3. Orchid Cellmark to Announce Fourth Quarter and Full Year 2007 Financial Results on March 6, 2008
4. Orchid Cellmark Appoints William J. Thomas Vice President and General Counsel
5. Orchid Cellmark Reports Third Quarter 2007 Financial Results
6. Neurotechnology Industry Reports Record Global Growth of $130.5 Billion in 2007
7. Micromet, Inc. Reports First Quarter 2008 Financial Results
8. Labopharm Reports Results for First Quarter Fiscal 2008
9. Caliper Life Sciences Reports First Quarter 2008 Results
10. US Oncology Reports First Quarter 2008 Results
11. The Ensign Group, Inc. Reports First Quarter 2008 Earnings

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... Benton Communications anno...ss growth system for retailers struggling to make ...PRWEB) November 26, 2009 -- Flu fears is the type ...to the emergency room, according to Dr. David Bent... released business growth system – The Rfac...
(Date:11/25/2009)...,, EMERYVILLE,Calif.,Nov.25/PRNewswire-FirstCal...announcedthatthecompanywillhosttwoinvestoreventsin...2009-9:00a.m.CT/10:00a.m.ET ,, Principalinves...filzomibinrelapsedand/orrefractorymultiplemyeloma,...)AnnualMeetingandExpositioninNewOrleans,LA.Thetele...
(Date:11/25/2009)...,, SILVERSPRING,Md.,Nov.25/PRNewswire-USNewswir...,sCenterforDrugEvaluationandResearch,titled"ADiffi...ppearsintheNov.26,2009issueofTheNewEnglandJournalo...-bin/prnh/20090824/FDALOGO ) ,, Inthearticle,Wo...cesstopainmedicationforthosewhoneeditandmanagingth...
(Date:11/25/2009)...Long-term survivors of testicular cancer who were ... severe side effects, including neurological side ...ere not treated with chemotherapy, according to a ...rnal of the National Cancer Institute . , Marian...keland University Hospital, in Bergen, Norway, and...
(Date:11/25/2009)...t study follow-up period was too short to draw def...NESDAY, Nov. 25 (HealthDay News) -- In diabetic pa...rs to be no difference in outcomes at one year whe...y with stenting, British researchers report. , ... diabetic patients with coronary artery disease. H...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3
...ils are at high risk of vitamin D deficiency, whic...ourne have found. A study reported in the journal...skinned and or veiled women had vitamin D levels b... and muscle disorders.// Ninety per cent of v...
...an inevitable consequence of ageing. As you age, y...h and thereby lose muscle strength. Meanwhile a ne...at muscle protein is made as quickly as it is brok...n muscle strength are commonly found as people get...
...s. A test for cardiac enzymes allows doctors to sp...ing a heart attack. Only 10 to 15 per cent of thos...n are actually having a heart attack. Other causes... to find out the cause.// According to Doctor...
...h) experience a greater risk of complications afte...a - which is most common in obese people - the mus...and so obstruct the airways. The person stops brea..., and 70 with normal sleep breathing patterns, all...
... life greatly increases the risk of heart diseases...dren. The key factor in heart disease is not...ast. It's long been known that babies with a low b...niversity of Southampton, and a team at the Nation...
...fically with the expectation of pain, as well as w... shown.The finding not only explains why certain m...ment of chronic pain, but it may also lead to bett... the brain activity of a group of people as they f...
Other Medicine News:
(Date:11/25/2009)...,, CHAPELHILL,N.C.,Nov.25/PRNewswire/--Cempra...rnandes,presidentandchiefexecutiveofficer,willpres...at8:50a.m.EST,December1,2009,atTheNewYorkPalaceHot...fthecompany,stwoleadingantibioticclinicalprogramsf...SA. ,, AboutCempraPharmaceuticals ,, Found...
(Date:11/25/2009)...,, NEWYORK,Nov.25/PRNewswire/--Reportlinker.c...initscatalogue: ,, IntranasalDrugDelivery-USMa...om/p0164267/Intranasal-Drug-Delivery---US-Market-T...iverymarketiswitnessinganexpansionoftherapeuticapp...uticdrugstothedeliveryofsystemictherapeuticdrugs.T...
(Date:11/25/2009)...,, FRAMINGHAM,Mass.andSYDNEY,Nov.25/PRNewswir...HTWR ;ASX:HIN),aleadinginnovatorandprovideroflessi...revolutionizingthetreatmentofadvancedheartfailure,...sentationatthe21stAnnualPiperJaffrayHealthCareConf...ferenceisbeingheldattheNewYorkPalaceHotel,December...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Microbix Files First Patent Applications On Novel Technology Platform For Large Semen Sexing Market 12957 1Microbix Files First Patent Applications On Novel Technology Platform For Large Semen Sexing Market 12957 2BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Demonstrates a 99 9997 25 Kill Rate Against Clostridium Difficile Spores 28C diff 29 in Indep 12955 1BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Demonstrates a 99 9997 25 Kill Rate Against Clostridium Difficile Spores 28C diff 29 in Indep 12955 2BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Demonstrates a 99 9997 25 Kill Rate Against Clostridium Difficile Spores 28C diff 29 in Indep 12955 3Vaccine May Someday Thwart Ear Infections 51195 1Vaccine May Someday Thwart Ear Infections 51195 2
... for,Translational Molecular Medicine (CTMM) - a D...esearch and development of new techniques for,the ...ced today that nine,projects will receive research... Dutch university medical centers, a broad spectru...ustry leaders including Philips and,Organon (a par...
...cal program of monoclonal ... April 1, 2008 ,Monogram Biosciences, Inc., (Nasda...o an agreement with Progenics Pharmaceuticals, Inc... testing for Progenics, clinical,development progr...antibody,being studied for the treatment of HIV. I...
Other Medicine Technology:Dutch Top Institute Allocates 150 Million Euro to R&D Projects Targeting Early Diagnosis and Treatment of Disease 2Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials 2Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials 3Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials 4Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials 5
ABL77 Blood Gas Analyzer
Rapidlink Critical Care Information Management System
Rapidlab 348 Blood Gas Analyzer
RapidLab 248 Blood Gas Analyzer
Medicine Products: